Lash, T.L. et al. 2010. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncologica. 49, 3 (Jan. 2010), 305–312. DOI:https://doi.org/10.3109/02841860903575273.